CN1446089A - 含有西酞普兰的药物组合物 - Google Patents

含有西酞普兰的药物组合物 Download PDF

Info

Publication number
CN1446089A
CN1446089A CN01813752A CN01813752A CN1446089A CN 1446089 A CN1446089 A CN 1446089A CN 01813752 A CN01813752 A CN 01813752A CN 01813752 A CN01813752 A CN 01813752A CN 1446089 A CN1446089 A CN 1446089A
Authority
CN
China
Prior art keywords
citalopram
unit dosage
dosage form
solid unit
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01813752A
Other languages
English (en)
Chinese (zh)
Inventor
K·利尔耶格伦
P·霍尔姆
O·尼尔森
S·瓦格纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1446089(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of CN1446089A publication Critical patent/CN1446089A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN01813752A 2000-08-10 2001-07-30 含有西酞普兰的药物组合物 Pending CN1446089A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
DKPA200001614 2000-10-27

Publications (1)

Publication Number Publication Date
CN1446089A true CN1446089A (zh) 2003-10-01

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01813752A Pending CN1446089A (zh) 2000-08-10 2001-07-30 含有西酞普兰的药物组合物

Country Status (34)

Country Link
EP (1) EP1318805A2 (cs)
JP (1) JP2003531153A (cs)
KR (1) KR20030024833A (cs)
CN (1) CN1446089A (cs)
AR (1) AR030095A1 (cs)
AT (1) AT5744U1 (cs)
AU (2) AU2001100198B4 (cs)
BE (1) BE1013559A6 (cs)
BG (1) BG107578A (cs)
BR (1) BR0113250A (cs)
CA (1) CA2353693C (cs)
CH (2) CH694241A5 (cs)
CZ (1) CZ2003397A3 (cs)
DE (2) DE10139115A1 (cs)
EA (1) EA200300247A1 (cs)
ES (1) ES2172481B2 (cs)
FI (1) FI5176U1 (cs)
FR (1) FR2812811B1 (cs)
GB (1) GB2368014B (cs)
GR (1) GR1004193B (cs)
HR (1) HRP20030054A2 (cs)
HU (1) HUP0103071A3 (cs)
IE (1) IES20010693A2 (cs)
IL (1) IL154050A0 (cs)
IS (1) IS6021A (cs)
IT (1) ITMI20011637A1 (cs)
MX (1) MXPA03000837A (cs)
NL (1) NL1018741C1 (cs)
NO (1) NO20013891L (cs)
NZ (1) NZ523785A (cs)
PL (1) PL359824A1 (cs)
SK (1) SK2842003A3 (cs)
WO (1) WO2001080619A2 (cs)
YU (1) YU9003A (cs)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
CN106389374A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
CN117771201A (zh) * 2023-09-28 2024-03-29 浙江普洛康裕制药有限公司 一种呋喃妥因大晶体胶囊及其制备工艺

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
AU2003287919B2 (en) * 2002-12-23 2009-11-12 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form
JP2026503161A (ja) 2023-02-07 2026-01-27 キナスト ラッセ Ａｐｉ含量が増加したエスシタロプラムまたはそのラセミ体の即時放出経口医薬製剤
CN116656399B (zh) * 2023-04-23 2026-03-03 攀钢集团西昌钢钒有限公司 一种并联式脱硫塔组

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
CN106389374A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
CN117771201A (zh) * 2023-09-28 2024-03-29 浙江普洛康裕制药有限公司 一种呋喃妥因大晶体胶囊及其制备工艺

Also Published As

Publication number Publication date
NZ523785A (en) 2004-09-24
NL1018741C1 (nl) 2002-02-12
NO20013891D0 (no) 2001-08-09
CH694241A5 (de) 2004-10-15
FR2812811A1 (fr) 2002-02-15
GB2368014B (en) 2004-06-23
EA200300247A1 (ru) 2003-06-26
WO2001080619A3 (en) 2002-02-21
GB2368014A (en) 2002-04-24
IS6021A (is) 2001-10-20
YU9003A (sh) 2006-05-25
HUP0103071A3 (en) 2002-12-28
ITMI20011637A1 (it) 2003-01-27
FR2812811B1 (fr) 2006-08-18
DE10139115A1 (de) 2002-03-28
JP2003531153A (ja) 2003-10-21
ES2172481B2 (es) 2004-08-01
AR030095A1 (es) 2003-08-13
DE20113195U1 (de) 2001-11-15
FI5176U1 (fi) 2001-12-27
CZ2003397A3 (cs) 2003-06-18
WO2001080619A2 (en) 2001-11-01
BE1013559A6 (fr) 2002-03-05
GB0118579D0 (en) 2001-09-19
HRP20030054A2 (en) 2005-02-28
SK2842003A3 (en) 2003-09-11
PL359824A1 (en) 2004-09-06
IL154050A0 (en) 2003-07-31
AU2001279591A1 (en) 2001-11-07
KR20030024833A (ko) 2003-03-26
IES20010693A2 (en) 2002-07-10
GR1004193B (el) 2003-03-24
CA2353693C (en) 2003-07-22
MXPA03000837A (es) 2003-06-06
BG107578A (bg) 2003-09-30
AU2001100198A4 (en) 2001-08-16
HU0103071D0 (en) 2001-10-28
GR20010100377A (el) 2002-09-06
AT5744U1 (de) 2002-11-25
NO20013891L (no) 2002-02-11
CH694242A5 (de) 2004-10-15
ITMI20011637A0 (it) 2001-07-27
EP1318805A2 (en) 2003-06-18
ES2172481A1 (es) 2002-09-16
AU2001100198B4 (en) 2002-06-13
CA2353693A1 (en) 2002-01-22
BR0113250A (pt) 2003-06-24
HUP0103071A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
CN1446089A (zh) 含有西酞普兰的药物组合物
JP5719811B2 (ja) エスシタロプラムを含む結晶性組成物
CN106890147A (zh) 含1‑(β‑D‑吡喃葡糖基)‑3‑(苯基噻吩基甲基)苯化合物的片剂
CN1155388C (zh) 利巴韦林口服固体剂型及其制备方法
CN1482903A (zh) 含有那格列奈的制剂
CN1154482C (zh) 粒状结晶布洛芬的包衣颗粒
CN1309570A (zh) 赋形剂
CN1058337A (zh) 含有2-巯基乙磺酸钠的片剂和药粒
RU2463039C2 (ru) Эсциталопрам и твердая фармацевтическая композиция, его содержащая
CN1268340C (zh) 含稠合吲哚化合物的药物组合物
HK1056684A (en) Pharmaceutical composition containing citalopram
CN1484523A (zh) 包含西酞普兰的药物组合物
CN101066267A (zh) 一种含有阿立哌唑微晶的固体口服药物组合物
CN1891299A (zh) 用于压片的糖醇组合物
JP2007526262A (ja) エスシタロプラムオキサレートを含む結晶質調合物
US20050053652A1 (en) Pharmaceutical composition containing citalopram
CN1943561A (zh) 普卢利沙星口腔崩解片及其制备方法
CN1925844A (zh) 含有依地普仑草酸盐的结晶组合物
HK1104215A (en) Crystalline composition containing escitalopram oxalate
CN1602948A (zh) 银杏叶分散片及其制备方法
HK1061211A (en) Pharmaceutical composition containing citalopram
CN1817341A (zh) 米格列奈固体缓释制剂及其制备方法
CN1634079A (zh) 一种复方戊酸雌二醇片及其制备方法
CN1795860A (zh) 一种遮掩不良口感口服咀嚼用组合物和其制备方法
HK1082407A (en) Crystalline composition containing escitalopram

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1056684

Country of ref document: HK